Jason D Kim

3PUBLICATIONS
3CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 13, 2023
Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study.

Anat Fisher, Jason D Kim, Colin R Dormuth

|Jan 27, 2022
Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia.

Anat Fisher, Jason D Kim, Greg Carney

|May 29, 2020
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia-An interim report.

Anat Fisher, Jason D Kim, Colin R Dormuth

Pageof 1

Frequent Collaborators

3 joint publications

Anat Fisher

3 joint publications

Colin R Dormuth

1 joint publications

Greg Carney